Serological surveillance of rubella in Europe: European Sero-Epidemiology Network (ESEN2).

A. Nardone*, Elizbeth Miller

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

30 Citations (Scopus)

Abstract

Serological surveillance is an important resource to evaluate vaccine programmes, especially for diseases such as rubella, where a sub-optimal programme can lead to an increase in morbidity. A coordinated vaccine policy in Europe is needed and the aim of the European Sero-Epidemiology Network (ESEN2) is to standardise serological surveillance in 22 countries for eight diseases, including rubella.

Original languageEnglish
Pages (from-to)5-7
Number of pages3
JournalEurosurveillance
Volume9
Issue number4
DOIs
Publication statusPublished - Apr 2004

Fingerprint

Dive into the research topics of 'Serological surveillance of rubella in Europe: European Sero-Epidemiology Network (ESEN2).'. Together they form a unique fingerprint.

Cite this